Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Wenzel Jahn

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Virchows Archiv : an International Journal of Pathology|July 15, 2016
Tumour heterogeneity: principles and practical consequencesGiorgio Stanta, Stephan Wenzel Jahn, Serena Bonin, et al.
Archives of Pathology & Laboratory Medicine|March 10, 2023
TERT Promoter Mutation c.-124C>T Commonly Occurs in Low-Grade Fibromatosis-like Metaplastic Breast CarcinomaGerald Webersinke, Jonathan Burghofer, Theodora Malli, et al.
Journal of Clinical Pathology|October 5, 2016
Critical evaluation of KCNJ3 gene product detection in human breast cancer: mRNA in situ hybridisation is superior to immunohistochemistrySarah Kammerer, Stephan Wenzel Jahn, Elke Winter, et al.
British Journal of Cancer|April 28, 2020
Clinically high-risk breast cancer displays markedly discordant molecular risk predictions between the MammaPrint and EndoPredict testsStephan Wenzel Jahn, Andreas Bösl, Oleksiy Tsybrovskyy, et al.
Oncotarget|November 12, 2016
KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patientsSarah Kammerer, Armin Sokolowski, Hubert Hackl, et al.
Breast Cancer Research : BCR|February 3, 2019
MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitorsDaniela Schwarzenbacher, Christiane Klec, Barbara Pasculli, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Virchows Archiv : an International Journal of Pathology|July 15, 2016
Tumour heterogeneity: principles and practical consequencesGiorgio Stanta, Stephan Wenzel Jahn, Serena Bonin, et al.
Archives of Pathology & Laboratory Medicine|March 10, 2023
TERT Promoter Mutation c.-124C>T Commonly Occurs in Low-Grade Fibromatosis-like Metaplastic Breast CarcinomaGerald Webersinke, Jonathan Burghofer, Theodora Malli, et al.
Journal of Clinical Pathology|October 5, 2016
Critical evaluation of KCNJ3 gene product detection in human breast cancer: mRNA in situ hybridisation is superior to immunohistochemistrySarah Kammerer, Stephan Wenzel Jahn, Elke Winter, et al.
British Journal of Cancer|April 28, 2020
Clinically high-risk breast cancer displays markedly discordant molecular risk predictions between the MammaPrint and EndoPredict testsStephan Wenzel Jahn, Andreas Bösl, Oleksiy Tsybrovskyy, et al.
Oncotarget|November 12, 2016
KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patientsSarah Kammerer, Armin Sokolowski, Hubert Hackl, et al.
Breast Cancer Research : BCR|February 3, 2019
MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitorsDaniela Schwarzenbacher, Christiane Klec, Barbara Pasculli, et al.
Pageof 1